Clinical and histological case study using resorbable hydroxylapatite for the repair of osseous defects prior to endosseous implant surgery.
A clinical case--a follow-up clinical and histological study--is presented in this paper, which describes the use of resorbable hydroxylapatite [OsteoGen (H.A. Resorb), Impladent, Inc., & GBD Marketing Group, Inc., Medical Division, Valley Stream, NY 11580] for the repair of a large mandibular lesion, followed by the placement of an endosseous dental implant six weeks after the graft placement. A comparison of the histological results of four-month and 14-month bone biopsies of resorbable hydroxylapatite grafts is included in this report.